ZFPM2 and autoimmune pancreatitis: In a small sample of early stage, Israeli, PD patients (N = 49), we genotyped and analyzed the association of the ZFPM2 rs12678719 AIP risk variant (discovered in our AIP–GWAS and validated in an additional population) with degree of NS pathway terminal degeneration, as evaluated by DAT-SPECT (25).